title: Leveraging leptin for type I diabetes?
authors.affiliation: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Kraus
authors.forename: Mark A
authors.initials: MA
authors.lastname: Herman
authors.forename: Barbara B
authors.initials: BB
authors.lastname: Kahn
mesh_terms: D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000008:administration & dosage / Q000172:deficiency / Q000627:therapeutic use; D020738:Leptin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D055442:Metabolome; D051379:Mice
chemical_list: D007328:Insulin; D020738:Leptin; D005947:Glucose